Jazz Pharmaceuticals PLC: JPMorgan raises target price to $310 from $300
JAZZ•JPMorgan raised its target price for Jazz Pharmaceuticals to $310 from $300.
Related News
Chainfir Capital flags rising Oracle credit risk as AI spending strains balance sheet
ORCL•
Reddit blasts Australia's 'inept' social media ban as challenge airs in court
RDDT•
CVR Energy reportedly nears more than $4 billion deal for Marathon's refineries
CVI•
KBW cuts Walker & Dunlop target price to $43 from $45
WD•
Goldman Sachs raises 2027 Europe gas price forecasts on Middle East supply, winter risks
UNG•